XML 68 R33.htm IDEA: XBRL DOCUMENT v3.25.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of liabilities measured at fair value on the condensed consolidated balance sheet
The following are the liabilities measured at fair value on the condensed consolidated balance sheet at June 30, 2025 and December 31, 2024 using quoted price in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3):
Level 1:
Quoted Prices
in Active
Markets for Identical
Assets
Level 2:
Significant
Other
Observable
Inputs
Level 3:
Significant
Unobservable
Inputs
Total at June 30,
2025
Total Gains (Losses) For The Three Months Ended June 30, 2025Total Gains (Losses) For The Six Months Ended June 30, 2025
Recurring fair value measurements
2024 February Institutional/Accredited Investor warrants$— $— $91,712 $91,712 $(18,042)$199,854 
2024 October Institutional/Accredited Investor Warrants$— $— $6,974 $6,974 $20,082 $285,260 
Senior Convertible Notes - October 2024$— $— $152,909 $152,909 $972,245 $(118,761)
Additional Investment Rights - October 2024$— $— $10,333 $10,333 $672,334 $(4,383)
2024 December Institutional/Accredited Investor Warrants$— $— $48,708 $48,708 $(8,396)$60,629 
2025 March Institutional/Accredited Investor Warrants$— $— $36,257 $36,257 $70,287 $70,287 
2025 April Institutional/Accredited Investor Warrants$— $— $31,683 $31,683 $— $— 
2025 May Institutional/Accredited Investor Warrants$— $— $139,917 $139,917 $— $— 
Senior Convertible Notes - May 2025$— $— $2,135,181 $2,135,181 $— $— 
Total recurring fair value measurements$— $— $2,653,674 $2,653,674 $1,708,510 $492,886 
Level 1:
Quoted Prices
in Active
Markets for Identical
Assets
Level 2:
Significant
Other
Observable
Inputs
Level 3:
Significant
Unobservable
Inputs
Total at December 31,
2024
Total Gains (Losses) For The Three Months Ended June 30, 2024Total Gains (Losses) For The Six Months Ended June 30, 2024
Recurring fair value measurements
2022 July Institutional/Accredited Investor Warrants$— $— $— $— $4,621 
2024 February Institutional/Accredited Investor warrants$— $— $291,566 $291,566 $1,584,770 $2,307,813 
2024 October Institutional/Accredited Investor Warrants$— $— $292,234 $292,234 $— $— 
Senior Convertible Notes - October 2024$— $— $2,475,162 $2,475,162 $— $— 
Additional Investment Rights - October 2024$— $— $5,950 $5,950 $— $— 
2024 December Institutional/Accredited Investor Warrants$— $— $109,337 $109,337 $— $— 
Derivative liability - non-controlling redeemable preferred shares$— $— $— $— $7,907 $(3,626)
Total recurring fair value measurements$— $— $3,174,249 $3,174,249 $1,592,680 $2,308,808 
Schedule of fair value on a recurring basis
The following is a reconciliation of the opening and closing balances for the liabilities related to the warrants (Note 11) and derivative liability - non-controlling redeemable preferred shares measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and six months ended June 30, 2025:
2024 February Institutional/Accredited Investor warrants2024 October Institutional/Accredited Investor WarrantsSenior Convertible Notes - October 2024Additional Investment Rights - October 20242024 December Institutional/Accredited Investor Warrants2025 March Institutional/Accredited Investor WarrantsSenior Convertible Notes - March 20252025 April Institutional/Accredited Investor Warrants2025 May Institutional/Accredited Investor WarrantsSenior Convertible Notes - May 2025
Balance at December 31, 2024$291,566 $292,234 $2,475,162 $5,950 $109,337 $— $— $— $— $— 
Initial fair value— — — — — 106,544 1,393,456 — — — 
Conversion of Convertible Notes— — (3,058,031)— — — — — — — 
Total (gains) losses for period included in earnings(217,896)(265,178)1,091,006 676,717 (69,025)— — — — — 
Balance at March 31, 202573,670 27,056 508,137 682,667 40,312 106,544 1,393,456 — — — 
Initial fair value— 31,683 139,917 2,135,181 
Conversion of Convertible Notes— — 617,017 — — — (1,393,456)— — — 
Total (gains) losses for period included in earnings18,042 (20,082)(972,245)(672,334)8,396 (70,287)— — — — 
Balance at June 30, 2025$91,712 $6,974 $152,909 $10,333 $48,708 $36,257 $— $31,683 $139,917 $2,135,181 
Schedule of carrying values and estimated fair values of debt instruments
The following outstanding debt obligations are reflected in the Company's condensed consolidated balance sheet at carrying value since the Company did not elect to remeasure the debt obligations to fair value at the end of each reporting period. The carrying values of these debt obligations approximate fair value due to the short-term maturity of these debt obligations.
June 30, 2025December 31, 2024
Fair ValueCarrying ValueFair ValueCarrying Value
Term loan$1,266,474 $1,266,474 $1,445,345 $1,445,345 
Promissory Notes - August 16, 2024 $901,558 $901,558 $884,676 $884,676 
Promissory Notes - August 27, 2024 $— $— $516,818 $516,818 
Promissory Notes - February 2025$276,293 $276,293 $— $— 
Senior Convertible Notes - December 2024$98,571 $98,571 $250,000 $250,000 
Promissory Notes - Fermata Energy II LLC$444,880 $444,880 $— $—